Evidence map›Paper›PMID 40478431›Full record

ArticleGeroScience2025

Age-related and dual task-induced gait alterations and asymmetry: optimizing the Semmelweis Study gait assessment protocol.

Peter Mukli, Mihaly Muranyi, Ágnes Lipecz, Zsofia Szarvas, Tamás Csípő, Anna Ungvari, Mónika Fekete, Vince Fazekas-Pongor, Anna Peterfi, Ágnes Fehér and 24 more

Abstract read
In one paragraph

Article in GeroScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Peter Mukli *Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Mihaly Muranyi *Vascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Ágnes Lipecz *Institute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Zsofia SzarvasVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Tamás CsípőInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Anna UngvariInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary. ungann2004@gmail.com.ORCID 0009-0001-5053-2828
Mónika FeketeInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Vince Fazekas-PongorInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Anna PeterfiInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Ágnes FehérInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Norbert DosaVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Noémi MózesInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Csilla KaposváriInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Anna AliquanderInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Wei Yi HungInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Dávid MajorInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Zalan KaposztaVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Attila MatiscsákFaculty of Health Sciences, Semmelweis University, Budapest, Hungary.
Gabriella DörnyeiFaculty of Health Sciences, Semmelweis University, Budapest, Hungary.
Zoltan BenyoInstitute of Translational Medicine, Semmelweis University, 1094, Budapest, Hungary.
Adam Nyul-TothVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Roland PataiVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Boglarka CsikInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Rafal GulejVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Attila KallaiInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Marton SandorInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Peter VargaInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Adam G TabakInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Stefano TarantiniVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Róza ÁdányInstitute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.
Béla MerkelyHeart and Vascular Center, Semmelweis University, Budapest, Hungary.
Anna CsiszarVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Andriy YabluchanskiyVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Zoltan UngvariVascular Cognitive Impairment, Neurodegeneration and Healthy Brain Aging Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Funding

Effects of NAD restoration on neurovascular coupling in community dwelling older adultsR01AG075834 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Aikaterini Thanou, Andriy Yabluchanskiy · 2022 to 2026
$3.2M
Time restricted eating for prevention of age-related vascular cognitive decline in older adultsR21AG080775 · NIA · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI TARANTINI, STEFANO, YABLUCHANSKIY, ANDRIY · 2023 to 2024
$399k
Nemzeti Kutatási, Fejlesztési és Innovaciós Alap TKP2021-NKTA-47NIA NIH HHS R01 AG075834NIA NIH HHS R21 AG080775
6 · The paper itself

Abstract

Gait alterations are recognized as early markers of age-related decline and cognitive impairment. Dual-task assessments, which impose cognitive load while walking, provide valuable insights into gait control limitations and cognitive-motor interactions in aging populations. This study evaluates age-related and cognitive load-induced changes in gait parameters, with a particular focus on asymmetry, and aims to optimize the gait assessment protocol for the Semmelweis Study framework. The Semmelweis Study is a large-scale workplace cohort investigating the determinants of unhealthy aging and promoting healthy brain aging by identifying risk factors and protective mechanisms influencing vascular, metabolic, and neurocognitive decline. As part of this initiative, gait analysis is emerging as a critical tool for assessing functional aging, detecting early signs of mobility and cognitive impairment, and contributing to biological age assessment. A cross-sectional analysis was conducted on adults aged 23 to 87 years using a pressure-sensitive walkway system. Participants were evaluated under single-task conditions (normal walking) and dual-task conditions (walking while performing a concurrent cognitive task). Spatiotemporal gait parameters, asymmetry indices, and dual-task costs were analyzed to assess age-related changes in gait performance and cognitive-motor interactions. Aging was associated with significant reductions in gait speed, step length, and stride length, along with a corresponding increase in gait asymmetry. Dual-task conditions exacerbated these alterations, indicating age-related impairments in cognitive-motor integration. Asymmetry indices were sensitive to aging effects, suggesting their potential as biomarkers for functional decline. The dual-task cost on gait was significantly greater in older adults, reinforcing the interplay between cognitive and motor systems in aging. Age-related gait alterations, particularly under cognitive load, underscore the importance of comprehensive gait assessments in aging research. Our findings contribute to the optimization of the Semmelweis Study gait assessment protocol by identifying key gait parameters that capture functional decline and biological aging. Integrating dual-task gait analysis into large-scale epidemiological studies has the potential to enhance early detection of brain health decline, refine biological age estimation, and guide targeted interventions to support healthy aging and neuromotor resilience.

Indexed as

AgingCognitive DysfunctionGaitGait AnalysisAdultAgedAged, 80 and overCognitionCross-Sectional StudiesFemaleHumansMaleMiddle AgedWalkingYoung AdultAgingCognitive loadDual-task walkingGait asymmetryGait variabilityMobility declineSemmelweis Study

Identifiers

PMID40478431
PMCPMC12638531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.